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roid hormone receptors (VDR and ER
) together with analysis
of NOD2/CARD15 mutations previously shown to be associ-
ated with GvHD and survival; clinical factors such as recipient
age, gender mismatch (female donor/male recipient), CMV sta-
tus, disease stage and stem cell source were included in the
analysis. Statistical modelling was carried out using binary lo-
gistic regression (for GvHD) and Cox regression (for survival).
Step-wise variable selection was used to identify a good set of
predictors of response. The prognostic index was a weighted
linear combination of these predictors and predictive accuracy
assessed for GvHD models. For the total cohort a good predic-
tive model for GvHD II-IV included absence of patient/donor
VDR and presence of patient IFN3/3 genotype; female to male
transplants; PBSC transplant and absence of T-cell depletion
(sensitivity 62%). GvHD associated with reduced intensity con-
ditioning occurred with the presence of patient/donor IL-1R

genotype, absence of VDR-1 donor genotype and absence of T
cell depletion (sensitivity 60%; overall correct prediction 77%).
In the acute leukaemia sub-group presence of patient IL-6 and
IFN genotype and absence of donor VDR-1 genotype inﬂu-
enced GvHD II-IV (64% sensitivity; overall correct prediction
68%). In the sub-group 	16 years the MDR-1 (12 allele A)
together with NOD2/CARD15 mutations inﬂuenced GvHD
outcome (speciﬁcity 58% sensitivity 80% overall correct pre-
diction 71%—Hosmer-Lemeshow test P  .896). Survival mod-
elling (162 of 244), using Cox regression for all data showed that
female to male transplants, donor age 	40 and CMV positivity
together with absence of IFN3/3 donor genotype and presence
of any NOD2 variable in the patient were the most signiﬁcant
variables and the best predictors of decreased survival.
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CHARACTERIZATION OF T CELL SPECIFICITIES RESPONSIBLE FOR DIF-
FERENTIAL GVHD AND ANTI-TUMOR-REACTIVITY INDUCED BY DONOR
LYMPHOCYTE INFUSION
Falkenburg, J.H.F.1, Slager, I.1, van Bergen, K.1, van Kester, M.1,
Jedema, I.1, van Luxemburg-Heijs, S.1, Heemskerk, M.1, Willemze, R.1
1Leiden University Medical Center, Leiden, The Netherlands.
Direct cloning using cell sorting of tumor-reactive T cells
from patients successfully responding to donor lymphocyte in-
fusion (DLI) as a treatment of relapsed leukemia or multiple
myeloma after allogeneic stem cell transplantation (SCT) re-
vealed the simultaneous presence of multiple clonal T cell
responses capable of killing the malignant cells during the clin-
ical response. In addition to the presence of known minor
histocompatibility antigen (mHag) speciﬁc T cell responses
against HA-1, HA-2, BCL2-A1 and HY, two new mHag were
identiﬁed. One of the speciﬁcities was characterized to be de-
rived from the endothelial cell growth factor-1 (ECGF-1) gene.
In addition, a new HLA-A2 restricted mHag derived from an
alternative reading frame from a broadly expressed protein was
found to be a target for one of the dominant T cell responses in
a patient with multiple myeloma responding to DLI. Some of
these mHags were exclusively expressed in hematopoietic cells,
whereas others were broadly expressed in both hematopoietic
and non-hematopoietic cells. Despite the broad tissue distribu-
tion of some mHag we found high frequencies of these mHag
speciﬁc T cells up to 3% of circulating T cells also in patients
suffering from only limited GVHD. These results illustrated
that not only the tissue distribution of the proteins indicated the
balance between GVHD and graft versus tumor (GVT) reac-
tivity. Using a panel of primary target cells we demonstrated
differential recognition of non-activated versus activated cells
from patients and donors by T cells speciﬁc for broadly ex-
pressed antigen. The activation state of the target cells corre-
sponded with the recognition by certain T cells against broadly
expressed antigens, whereas T cells recognizing hematopoiesis
speciﬁc mHag like HA-1 were capable of killing both activated
and non-activated hematopoietic cells. Our results illustrate that
T cell responses against broadly expressed antigens can mediate
a GVT reactivity with no or limited GVHD in patients not
suffering from concurrent diseases. These results also explain an
increased susceptibility of target organs for recognition by
mHag speciﬁc T cells during infectious diseases resulting in
increased GVHD.
27
DIFFERENTIAL EFFECTS OF ORGAN-DERIVED HOST-TYPE DENDRITIC
CELLS ON ALLOREACTIVE DONOR T CELLS IN A MURINE BONE MAR-
ROW TRANSPLANTATION MODEL
Kim, T.D.1, Zakrzewski, J.L.1, Kochman, A.1, Suh, D.1,
Terwey, T.H.1, Borsotti, C.1, van den Brink, M.R.1 1Department of
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Host dendritic cells are considered critical for the induction of
graft-versus-host disease. In addition to their priming function,
dendritic cells were recently shown to induce organ-tropism de-
pending on their tissue of origin. Here, we sought to examine the
effect of different organ-derived dendritic cells on allogeneic T
cells and their capacity to induce GvHD. FLT3L-expanded host-
type dendritic cells from GvHD target organs (liver, spleen) or
their draining secondary lymphoid tissues (peripheral lymph nodes
for skin, mesenteric lymph nodes for gut) effectively primed naı¨ve
splenic donor-type T cells after short-term coculture in vitro.
Overall levels of alloreactivity as analysed by expression of activa-
tion markers, detection of cytokine secretion and in vitro prolifer-
ation in an MLR were comparable. However, there were signiﬁ-
cantly divergent expression patterns of homing molecules between
gut-derived and all other dendritic cell types. Whereas the expres-
sion of the intestinal homing molecule LPAM-1 (alpha-4, beta-7
integrin) was signiﬁcantly higher on T cells stimulated with gut-
derived dendritic cells, the expression of E- and P-selectin ligands
was signiﬁcantly lower. Interestingly, the expression of E-selectin
ligands was preferentially induced on CD8 T cells, whereas the
upregulation of P-selectin ligands was comparable on CD4 and
CD8 T cells. Both LPAM-1 subunits were upregulated with
alpha-4 integrin being the highest and being associated with up-
regulation of VLA-4 (alpha-4, beta-1 integrin) which has previ-
ously been implicated in liver homing. However, the latter was not
induced by liver-derived dendritic cells. In a murine bone marrow
transplantation model (B10.BR into B6, 1  106 T cells) these
cultured T cells expectedly induced less aggressive GvHD as com-
pared to naive control T cells with the exception of T cells stim-
ulated with dendritic cells from mesenteric lymph nodes. Survival
in this group was signiﬁcantly shorter than in the spleen, liver and
peripheral lymph node groups and not different from the control T
cell group. In conclusion, we have shown for the ﬁrst time that
dendritic cells can efﬁciently induce speciﬁc homing molecules on
alloreactive T cells and that an induced ‘gut-homing phenotype’
correlates with increased GvHD mortality after murine bone mar-
row transplantation.
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THE DETECTION OF ACTIVATED CIRCULATING CMRF-44 POSITIVE
CD11c DENDRITIC CELLS IS CLOSELY ASSOCIATED WITH THE SE-
VERITY OF ACUTE GVHD AFTER ALLOGENEIC HEMOPOIETIC STEM
CELL TRANSPLANT
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Dendritic cells (DC) are considered central to the development
of graft versus host disease (GVHD) following allogeneic hemo-
poietic stem cell transplantation (alloHSCT). Both donor and host
DC are thought to initiate allogeneic immune responses by pre-
senting host antigens to donor T lymphocytes. We prospectively
studied the potential of the monoclonal antibody CMRF-44 to
identify activated circulating blood DC, as a predictive marker of
acute GVHD. Peripheral blood was taken from 40 patients, twice
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